Preoperative mFOLFIRINOX versus PAXG for stage I-III resectable and borderline resectable pancreatic ductal adenocarcinoma (PACT-21 CASSANDRA): results of the first randomisation analysis of a randomised, open-label, 2 x 2 factorial phase 3 trial. (linkinghub.elsevier.com)

Authors: Reni M … Falconi M Journal: The Lancet Published: 2025-11-20 DOI: https://doi.org/10.1016/S0140-6736(25)01685-X